NEW YORK--(BUSINESS WIRE)--#Accenture--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Bristol-Myers Squibb (NYSE:BMY) has selected the Medidata Clinical Cloud® to help manage, monitor and analyze its clinical trials. Medidata’s cutting-edge technology platform will support Bristol-Myers Squibb’s research capabilities in immuno-oncology, oncology, immunoscience, virology, cardiovascular, fibrotic diseases, genetically
![]()
↧